Delivery Order SPE2DB20D2014-SPE2DB25FC94T
- Not listed
- The Defense Logistics Agency awarded a $5,007.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a $6,700.07 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This firm fixed-price delivery order, which is expected to be completed by August 14, 2025, was competitively awarded with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $12,545.94 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $14,019.75 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $29,315.47 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count unit) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $10,547.87 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, due for completion by August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $8,409.03 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The competitively awarded, firm fixed-price delivery order was placed on August 8, 2025, with an ultimate completion date of August 11, 2025. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,582.67 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order is set to be completed by August 26, 2025, just one day after the award date of August 25, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,052.63 to AmerisourceBergen Drug Corp on August 18, 2025, for TRELEGY ELLIPTA 100-62.5-25, a respiratory medication supplied in a 60-dose inhaler. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $10,155.29 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count units). This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 29, 2025. The contract carries no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC94TDelivery Order
The Defense Logistics Agency awarded a $10,713.15 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of TRELEGY ELLIPTA 100-62.5-25 (a combination inhalation powder medication for chronic obstructive pulmonary disease) in a 60-dose package. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 9, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract involves no set-aside designation and will be fulfilled from the vendor's Conshohocken, Pennsylvania location, which serves as both the place of performance and the company's corporate headquarters. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company holds a $999,999,999 IDC with DLA Troop Support Medical (designated SPE2DX) through December 2026, which functions as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. This delivery order exemplifies the company's established capability to fulfill federal pharmaceutical requirements through competitive procurement and demonstrates its role in supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 9/8/25 |